Roh J K, Lee T G, Wie B A, Lee S B, Park S H, Chang K H
Department of Neurology, Seoul National University, College of Medicine, Republic of Korea.
Neurology. 1994 Jun;44(6):1064-8. doi: 10.1212/wnl.44.6.1064.
We performed pretreatment brain MRIs in 25 patients with neurologically symptomatic Wilson's disease (WD) and clinical and MRI follow-up in 16 of them. All 25 pretreatment MRIs revealed abnormalities, with abnormal high-signal intensity (HSI) in bilateral thalami being the most common (92%). HSI lesions in the brainstem (84%) and the basal ganglia (72%) were also common. Brain atrophy was present in 88% of the 25 patients. In the follow-up period of 5 to 24 months, during which the patients were treated with D-penicillamine, both HSI lesions and neurologic symptoms improved in 88% of the 16 patients, but the brain atrophy did not change.
我们对25例有神经症状的威尔逊病(WD)患者进行了治疗前脑部磁共振成像(MRI)检查,并对其中16例进行了临床及MRI随访。所有25例治疗前MRI均显示异常,双侧丘脑异常高信号强度(HSI)最为常见(92%)。脑干(84%)和基底节(72%)的HSI病变也很常见。25例患者中有88%存在脑萎缩。在5至24个月的随访期内,患者接受青霉胺治疗,16例患者中有88%的HSI病变和神经症状均有改善,但脑萎缩没有变化。